BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32466659)

  • 1. Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
    Herrera ML; Deza-Ponzio R; Ghersi MS; de la Villarmois EA; Virgolini MB; Pérez MF; Molina VA; Bellini MJ; Hereñú CB
    ASN Neuro; 2020; 12():1759091420925977. PubMed ID: 32466659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrosative and cognitive effects of chronic L-DOPA administration in rats with intra-nigral 6-OHDA lesion.
    Ramírez-García G; Palafox-Sánchez V; Limón ID
    Neuroscience; 2015 Apr; 290():492-508. PubMed ID: 25644418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats.
    Matheus FC; Rial D; Real JI; Lemos C; Ben J; Guaita GO; Pita IR; Sequeira AC; Pereira FC; Walz R; Takahashi RN; Bertoglio LJ; Da Cunha C; Cunha RA; Prediger RD
    Behav Brain Res; 2016 Mar; 301():43-54. PubMed ID: 26707254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
    Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
    Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 6-hydroxydopamine-induced nigrostriatal neurodegeneration produces microglia-like NG2 glial cells in the rat substantia nigra.
    Kitamura Y; Inden M; Minamino H; Abe M; Takata K; Taniguchi T
    Glia; 2010 Nov; 58(14):1686-700. PubMed ID: 20629191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.
    Ambrosi G; Armentero MT; Levandis G; Bramanti P; Nappi G; Blandini F
    Brain Res Bull; 2010 Apr; 82(1-2):29-38. PubMed ID: 20100549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
    Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
    Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity.
    Saura J; Parés M; Bové J; Pezzi S; Alberch J; Marin C; Tolosa E; Martí MJ
    J Neurochem; 2003 May; 85(3):651-61. PubMed ID: 12694391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism.
    Gonzalez-Aparicio R; Blanco E; Serrano A; Pavon FJ; Parsons LH; Maldonado R; Robledo P; Fernandez-Espejo E; de Fonseca FR
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):455-68. PubMed ID: 24169105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.
    Ambrosi G; Kustrimovic N; Siani F; Rasini E; Cerri S; Ghezzi C; Dicorato G; Caputo S; Marino F; Cosentino M; Blandini F
    Neurotox Res; 2017 Jul; 32(1):71-81. PubMed ID: 28285346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine.
    Rodrigues RW; Gomide VC; Chadi G
    Int J Neurosci; 2001 Jul; 109(1-2):91-126. PubMed ID: 11699344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.
    Silva C; Fuxe K; Chadi G
    J Neural Transm Suppl; 2009; (73):185-202. PubMed ID: 20411778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease.
    Solis O; Limón DI; Flores-Hernández J; Flores G
    Synapse; 2007 Jun; 61(6):450-8. PubMed ID: 17372982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apelin-13 ameliorates cognitive impairments in 6-hydroxydopamine-induced substantia nigra lesion in rats.
    Haghparast E; Esmaeili-Mahani S; Abbasnejad M; Sheibani V
    Neuropeptides; 2018 Apr; 68():28-35. PubMed ID: 29329678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
    Gomide V; Bibancos T; Chadi G
    Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerium oxide nanoparticles could ameliorate behavioral and neurochemical impairments in 6-hydroxydopamine induced Parkinson's disease in rats.
    Hegazy MA; Maklad HM; Samy DM; Abdelmonsif DA; El Sabaa BM; Elnozahy FY
    Neurochem Int; 2017 Sep; 108():361-371. PubMed ID: 28527632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner.
    Boshoff EL; Fletcher EJR; Duty S
    Neuropharmacology; 2018 Jul; 137():156-163. PubMed ID: 29698669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging.
    Kondoh T; Bannai M; Nishino H; Torii K
    Exp Neurol; 2005 Mar; 192(1):194-202. PubMed ID: 15698634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.
    Deumens R; Blokland A; Prickaerts J
    Exp Neurol; 2002 Jun; 175(2):303-17. PubMed ID: 12061862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.